The Sum of Many Small Changes: MicroRNAs Are Specifically and Potentially Globally Altered by Vitamin D3 Metabolites

Overview

Journal J Steroid Biochem Mol Biol

Specialties Biochemistry
Molecular Biology

Date 2013 Jan 22

PMID 23333596

Citations 21

Authors

Angeline A Giangreco

Larisa Nonn

Affiliations

Soon will be listed here.

Abstract

Vitamin D3 deficiency is rampant which may contribute to increased risk of many diseases including cancer, cardiovascular disease and autoimmune disorders. Genomic activity of the active metabolite 1,25-dihydroxyvitamin D (1,25D) mediates most vitamin D3's actions and many gene targets of 1,25D have been characterized. As the importance of non-coding RNAs has emerged, the ability of vitamin D3via 1,25D to regulate microRNAs (miRNAs) has been demonstrated in several cancer cell lines, patient tissue and sera. In vitamin D3 intervention patient trials, significant differences in miRNAs are observed between treatment groups and/or between baseline and followup. In patient sera from population studies, specific miRNA differences associate with serum levels of 25D. The findings thus far indicate that dietary vitamin D3 in patients and 1,25D in vitro not only regulate specific miRNA(s), but may also globally upregulate miRNA levels. This article is part of a Special Issue entitled 'Vitamin D Workshop'.

Citing Articles

sChemNET: a deep learning framework for predicting small molecules targeting microRNA function.

Galeano D, Imrat , Haltom J, Andolino C, Yousey A, Zaksas V Nat Commun. 2024; 15(1):9149.

PMID: 39443444 PMC: 11500171. DOI: 10.1038/s41467-024-49813-w.

Extracellular Vesicle-Enclosed Oxidative Stress- and Inflammation-Related microRNAs as Potential Biomarkers of Vitamin D Responsivity: A Pilot Study on Inflammatory Bowel Disease Patients with or without COVID-19.

Ammirata G, Arigoni M, Licastro D, Caviglia G, Disabato M, Zubair G Antioxidants (Basel). 2024; 13(9).

PMID: 39334706 PMC: 11429492. DOI: 10.3390/antiox13091047.

MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products.

Atteia H Curr Pharm Biotechnol. 2024; 25(14):1791-1806.

PMID: 38178678 DOI: 10.2174/0113892010282155231222071903.

25-hydroxyvitamin D3 inhibits oxidative stress and ferroptosis in retinal microvascular endothelial cells induced by high glucose through down-regulation of miR-93.

Zhan D, Zhao J, Shi Q, Lou J, Wang W BMC Ophthalmol. 2023; 23(1):22.

PMID: 36639741 PMC: 9840274. DOI: 10.1186/s12886-022-02762-8.

Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases.

Uthaiah C, Beeraka N, Rajalakshmi R, Ramya C, Madhunapantula S Mol Neurobiol. 2022; 59(7):4065-4105.

PMID: 35476289 DOI: 10.1007/s12035-022-02837-z.

References

Zhou Y, Ferguson J, Chang J, Kluger Y . Inter- and intra-combinatorial regulation by transcription factors and microRNAs. BMC Genomics. 2007; 8:396. PMC: 2206040. DOI: 10.1186/1471-2164-8-396. View

Halsall J, Osborne J, Potter L, Pringle J, Hutchinson P . A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma. Br J Cancer. 2004; 91(4):765-70. PMC: 2364794. DOI: 10.1038/sj.bjc.6602006. View

Giovannucci E . The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005; 16(2):83-95. DOI: 10.1007/s10552-004-1661-4. View

Shui I, Mucci L, Kraft P, Tamimi R, Lindstrom S, Penney K . Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012; 104(9):690-9. PMC: 3341310. DOI: 10.1093/jnci/djs189. View

Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y . 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 1981; 102(3):937-43. DOI: 10.1016/0006-291x(81)91628-4. View

Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T . MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009; 125(6):1328-33. DOI: 10.1002/ijc.24459. View

Glud M, Manfe V, Biskup E, Holst L, Dirksen A, Hastrup N . MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res. 2011; 21(3):253-6. DOI: 10.1097/CMR.0b013e328345333b. View

Zhang J, Chalmers M, Stayrook K, Burris L, Wang Y, Busby S . DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol. 2011; 18(5):556-63. PMC: 3087838. DOI: 10.1038/nsmb.2046. View

Newmark H, Yang K, Kurihara N, Fan K, Augenlicht L, Lipkin M . Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2008; 30(1):88-92. PMC: 2722141. DOI: 10.1093/carcin/bgn229. View

10.

Norman A, Mizwicki M, Norman D . Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov. 2004; 3(1):27-41. DOI: 10.1038/nrd1283. View

11.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

12.

Gandini S, Sera F, Cattaruzza M, Pasquini P, Picconi O, Boyle P . Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2004; 41(1):45-60. DOI: 10.1016/j.ejca.2004.10.016. View

13.

Enquobahrie D, Williams M, Qiu C, Siscovick D, Sorensen T . Global maternal early pregnancy peripheral blood mRNA and miRNA expression profiles according to plasma 25-hydroxyvitamin D concentrations. J Matern Fetal Neonatal Med. 2011; 24(8):1002-12. PMC: 4030419. DOI: 10.3109/14767058.2010.538454. View

14.

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

15.

Molica S, Digiesi G, Antenucci A, Levato L, Mirabelli R, Molica M . Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL). Leuk Res. 2011; 36(4):443-7. DOI: 10.1016/j.leukres.2011.10.004. View

16.

Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault M, Clavel-Chapelon F . Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2010; 20(1):187-98. DOI: 10.1158/1055-9965.EPI-10-1039. View

17.

Tong A, Fulgham P, Jay C, Chen P, Khalil I, Liu S . MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther. 2008; 16(3):206-16. DOI: 10.1038/cgt.2008.77. View

18.

Schaefer A, Jung M, Mollenkopf H, Wagner I, Stephan C, Jentzmik F . Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2009; 126(5):1166-76. DOI: 10.1002/ijc.24827. View

19.

Calin G, Liu C, Sevignani C, Ferracin M, Felli N, Dumitru C . MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004; 101(32):11755-60. PMC: 511048. DOI: 10.1073/pnas.0404432101. View

20.

Stadler B, Ruohola-Baker H . Small RNAs: keeping stem cells in line. Cell. 2008; 132(4):563-6. PMC: 2925130. DOI: 10.1016/j.cell.2008.02.005. View